Cargando…
Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis
Gold nanobeacons can be used as a powerful tool for cancer theranostics. Here, we proposed a nanomaterial platform based on gold nanobeacons to detect, target and inhibit the expression of a mutant Kras gene in an in vivo murine gastric cancer model. The conjugation of fluorescently-labeled antisens...
Autores principales: | Bao, Chenchen, Conde, João, Curtin, James, Artzi, Natalie, Tian, Furong, Cui, Daxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507177/ https://www.ncbi.nlm.nih.gov/pubmed/26189409 http://dx.doi.org/10.1038/srep12297 |
Ejemplares similares
-
Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids
por: Sousa, Diana Pacheco, et al.
Publicado: (2022) -
Gold Nanobeacons for Tracking Gene Silencing in Zebrafish
por: Cordeiro, Milton, et al.
Publicado: (2017) -
Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020) -
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
por: Li, Yanan, et al.
Publicado: (2021) -
BioCode gold-nanobeacon for the detection of fusion transcripts causing chronic myeloid leukemia
por: Cordeiro, M., et al.
Publicado: (2016)